Skip to main content
Caplight Logo









Cinapsis

Cinapsis

Private
LondonHealthcare & Life Scienceshttps://www.cinapsis.org/

Last Round

Grant

Apr 1, 2021

Total Funding Raised

$3.42M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Cinapsis operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Grant round in April 2021.

Cinapsis is a healthcare technology company that provides a cloud-based clinical communication and electronic referral management platform for primary and secondary care providers.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, Enterprise Communication, Healthcare Analytics, EHR & EMR

Business Model

B2G

Customer Profile

Subscription SaaS, Government Contracts

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Cinapsis Comparables

Compare Cinapsis with similar companies based on industry and business-model similarity.

Cinapsis comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Teladoc Health, Inc.
80%
NEC Corporation
78%
Lutra Health
77%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Cinapsis Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantApr 1, 2021
GrantJul 16, 2020
AcceleratorSep 12, 2016
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Cinapsis Investors

Notable investors and investment history

Cinapsis investors
InvestorRounds
DigitalHealth.LondonAccelerator
NHS ImprovementGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2026

    Monthly visitors grew 43% MoM, reaching 21.1K.

  • May 19, 2026

    Monthly visitors increased 183% MoM, reaching 13.6K.

Book a demo to see all signals

For institutional investors. Book with your work email.

Cinapsis Filings

Explore SEC and related filing metadata, where available.

Cinapsis filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Cinapsis's valuation, stock price, and market status.

Is Cinapsis a public or private company?

Cinapsis is a private company.

What is the current stock price of Cinapsis?

Cinapsis is a private company, so its shares have no public market price. Caplight tracks Cinapsis's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Cinapsis worth (valuation)?

Valuation information for Cinapsis is not publicly available.

Can I buy Cinapsis stock?

Cinapsis shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Cinapsis's last funding round?

Cinapsis's most recent funding round was Grant on April 1, 2021.

Who are the main investors in Cinapsis?

Key investors in Cinapsis include DigitalHealth.London, NHS Improvement.

Will Cinapsis IPO soon?

No public IPO plans have been announced for Cinapsis.

How can I track Cinapsis secondary market activity?

Caplight tracks bids, offers, and trades in Cinapsis's shares on secondary markets.

Firmographic Details

HeadquartersLondon
Employee Range11
Year Founded2015
Last FundingApr 1, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?